Cardionet, LLC v. Mednet Healthcare Technologies, Inc.
146 F. Supp. 3d 671
E.D. Pa.2015Background
- CardioNet sued Mednet-affiliates and customers (including MedTel24) for infringing five patents via the Heartrak ECAT System (Monitor, Communicator, CardioStation software). Parties entered a Consent Judgment on Jan 31, 2014 resolving infringement and defining the ECAT System and injunction terms.
- Consent Judgment: ¶13 adjudged use/sale of the ECAT System infringes; ¶14 permanently enjoined defendants from infringing; ¶16 granted MedTel a one-year limited license to make/use/sell the ECAT System and required delivery of all inventories (including CardioStation source code/software) to CardioNet within 15 days after the one-year date; ¶19 barred transfers/disclosures of ECAT materials to third parties outside conventional monitoring activities without CardioNet’s written permission.
- After the one-year license expired (Jan 31, 2015), MedTel continued to provide ECAT monitoring using CardioStation and retained copies of the software; it also gave an Israeli engineering firm access to CardioStation/source code while developing alternative software.
- CardioNet moved for contempt and damages (Feb 2015). Court denied MedTel’s Rule 60(b) and stay motions (July 22, 2015), held contempt hearings (Sept 2015), and previously found MedTel in contempt of ¶16 and ordered delivery (Oct 2, 2015).
- This memorandum: holds MedTel in contempt of ¶14 (use/infringement) as well as ¶16, awards lost-profits and attorneys’ fees for the contempt proceeding, declines contempt finding on ¶19 (ambiguous whether Israeli firm was a “third party”), and denies sanctions against MedTel and its counsel.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether MedTel’s continued monitoring services after the license expired violated ¶14 (use/infringement) | Continued monitoring using CardioStation + reliance on physician-owned Monitors/Communicators constitutes "use" of the ECAT System and thus infringement under the Consent Judgment. | MedTel said it used only the software (not the Monitors/Communicators), so it did not "use" the complete ECAT System as defined and thus did not infringe; also raised patent exhaustion and divided-infringement defenses. | Court: MedTel’s monitoring requires putting Monitor, Communicator and software into service — constitutes "use" under the Consent Judgment; exhaustion/divided-infringement defenses foreclosed by Consent Judgment’s definition. Contempt for ¶14 proven. |
| Whether MedTel violated ¶16 by failing to deliver inventories (software/source code) after the one-year license | CardioNet: MedTel retained copies of CardioStation and source code and failed to deliver them, violating ¶16. | MedTel argued software had noninfringing uses and ¶16 shouldn’t require surrender; raised patent-misuse/antitrust concerns. | Court: ¶16 required delivery; patent-misuse argument rejected (no authority to override explicit settlement term). Contempt for ¶16 reaffirmed and compliance ordered. |
| Whether MedTel violated ¶19 by disclosing software/source code to the Israeli firm | CardioNet: disclosure to the Israeli firm without prior written permission violated ¶19 (unauthorized third-party disclosure). | MedTel: Israeli firm was agent/acting in concert (falls within MedTel’s ¶14(b) definition), and disclosure was within conventional monitoring-support activities. | Court: Ambiguity whether firm was a “third party” (¶14(b) potentially covers agents/actors in concert) and disclosure was at least partly outside conventional monitoring activities; because ambiguities favor defendant in contempt context, Court declined to find contempt on ¶19. |
| Remedies: Damages and sanctions — (lost profits, costs, attorneys’ fees; sanctions against counsel) | CardioNet sought lost profits for monitoring sessions provided during contempt period, direct expenses (wireless charges), and attorneys’ fees; sought Rule 11/§1927/inherent sanctions against MedTel and counsel. | MedTel disputed causation and conversion assumptions for lost profits; argued wireless-charge claims are arbitrable; denied counsel’s conduct warranted sanctions. | Court: Applies preponderance standard to damages; awards lost profits on 50% of MedTel sessions during the period ($681,256.03 for Feb 1–Aug 15, 2015 plus later-period amount to be calculated), declines to award wireless-account expenses (left to arbitration), awards attorneys’ fees for contempt prosecution (fee petition ordered), and denies Rule 11/§1927/inherent sanctions. |
Key Cases Cited
- Shillitani v. United States, 384 U.S. 364 (1966) (district courts have inherent power to enforce orders via civil contempt)
- Interdynamics, Inc. v. Firma Wolf, 653 F.2d 93 (3d Cir. 1981) (consent judgments are judicial acts enforceable by contempt)
- Marshak v. Treadwell, 595 F.3d 478 (3d Cir. 2009) (elements plaintiff must prove for civil contempt)
- John T. ex rel. Paul T. v. Del. Cnty. Intermediate Unit, 318 F.3d 545 (3d Cir. 2003) (contumacious conduct and burden rules)
- Robin Woods, Inc. v. Woods, 28 F.3d 396 (3d Cir. 1994) (ambiguities in orders resolved for benefit of alleged contemnor)
- Harley-Davidson, Inc. v. Morris, 19 F.3d 142 (3d Cir. 1994) (good faith is not a defense to civil contempt)
- Quanta Computer, Inc. v. LG Electronics, Inc., 553 U.S. 617 (2008) (doctrine of patent exhaustion)
- Akamai Techs., Inc. v. Limelight Networks, Inc., 797 F.3d 1020 (Fed. Cir. 2015) (en banc) (law of divided infringement attribution)
- Princo Corp. v. Int’l Trade Comm’n, 616 F.3d 1318 (Fed. Cir. 2010) (doctrine of patent misuse and its contours)
